Meloxicam in sheep and goats

The plasma concentration versus time data of meloxicam in both sheep and goats were adequately described by a two-compartment open model. The values obtained for sheep and goats for distribution half-life, volume of distribution at steady state and volume of the central compartment were almost similar in sheep and goats.

Oral meloxicam is delivered with a syringe or a dosing gun to the back of sheep and goats so repeat treatments may be required. In Canada meloxicam

sheep and goats so repeat treatments may be required. In Canada meloxicam is registered for controlling pain and inflammation in sheep. NSAIDs are an

Comparative plasma pharmacokinetics of meloxicam in sheep and goats following intravenous administration List of references Publications that cite this

Sheep and goats. Procedures. 1. Specific Concerns in Ruminant Pharmacokinetics of intravenously and orally administered meloxicam in sheep.

Meloxicam oral suspension was developed for cattle, sheep, goats, and horses to control pain and inflammation. The efficacy of MOS for

Meloxicam injection has recently been registered for use in cattle, sheep, pigs and horses, but not goats. Meloxicam buccalgesic products are registered for

by RS Yadav 2024half-life of meloxicam in goats compared to sheep, horse and dogs is expected. Comparative plasma pharmacokinetics of meloxicam in sheep and goats following

Meloxicam was not detectable in plasma of goats at 72 h after drug administration. The pharmacokinetic parameters of meloxicam in sheep and goats following its intravenous administration at a single dose of 0.5 mg kg 1 are shown in Table 2. The t1/2, MRT, AUC and ClB of meloxicam in sheep were significantly different from those of goats. 4.